Comoros vs Papua New Guinea: Treatment coverage for lymphatic filariasis

Comoros
0.0%
in 2022
Papua New Guinea
5.7%
in 2024
Comoros rank
55th
Papua New Guinea rank
53rd

Treatment coverage for lymphatic filariasis over time

  • Comoros
  • Papua New Guinea
020406080200120122024

How they compare

Papua New Guinea currently reports 5.7% against 0.0% in Comoros, a difference of 5.7%.

The two have swapped places 2 times across 14 shared years of data; in 2005 it was Papua New Guinea ahead.

Comoros ranks 55th and Papua New Guinea ranks 53rd of 66 countries.

Across the 3 decades both report, Comoros averaged higher in 2 and Papua New Guinea in 1.

Head to head by decade

Decade Comoros Papua New Guinea Difference Ahead
2000s 1.7% 5.7% 4.0% Papua New Guinea
2010s 13.7% 1.6% 12.1% Comoros
2020s 29.7% 1.4% 28.3% Comoros

Averages of every year both report within each decade.

Frequently asked questions

Which has higher treatment coverage for lymphatic filariasis, Comoros or Papua New Guinea?
Papua New Guinea, at 5.7% against 0.0% in Comoros as of 2024.
What is the difference in treatment coverage for lymphatic filariasis between Comoros and Papua New Guinea?
5.7%, with Papua New Guinea ahead.
How many years of comparable data are there for Comoros and Papua New Guinea?
14 years are reported by both, from 2005 to 2022.
How do Comoros and Papua New Guinea rank globally for treatment coverage for lymphatic filariasis?
Comoros ranks 55th and Papua New Guinea ranks 53rd of 66 countries.
Where does this data come from?
World Health Organization (2025) – with minor processing by Our World in Data, published as Treatment coverage for lymphatic filariasis. Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

About this data

Indicator
Treatment coverage for lymphatic filariasis
Unit
%
Source
World Health Organization (2025) – with minor processing by Our World in Data
Licence
CC BY 4.0 (Our World in Data)
Coverage
66 places, 966 data points, 1999–2024
Last refreshed

Drug coverage out of estimated population who require it.